2019 SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

November 20 - 21, 2019
Marriott Desert Ridge Hotel, Phoenix, Arizona

Held in conjunction with the 24th Annual Meeting and Education Day of
the Society for Neuro-Oncology



Conference Overview
The Society for Neuro-Oncology (SNO) and the Society for CNS Interstitial Delivery of Therapeutics (SCIDOT) invite you to attend the 2019 SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS which will be held on November 20-21, 2019 at the Marriott Desert Ridge Hotel in Phoenix, Arizona (in conjunction with the SNO Annual Meeting).  This important meeting will focus on the critical theme of drug delivery to the CNS, highlighting barriers, as well as potential new avenues and ground-breaking research. The program committee is developing a robust program that will include invited talks from industry professionals and leaders in the field, as well as select oral and poster abstract presentations.

Session Topics
BBB physiology
New Drugs/Therapeutics – preclinical
Clinical Trials
Non-tumor applications
Modeling and Imaging
New Technologies

Program Committee:
SCIDOT Chair - Michael Vogelbaum, MD, PhD, Moffitt Cancer Center
SNO Chair - Nathalie Agar, PhD, Dana-Farber Cancer Institute

Krystof Bankiewicz, MD, PhD, University of California, San Francisco
Waldemar Debinski, MD, PhD, Wake Forest University
William Elmquist, PhD, University of Minnesota
Raghu Raghavan, PhD, Therataxis, LLC
Nader Sanai, MD, Barrow Neurological Institute
Lisa Shafer, PhD, Neuro Connect Consulting
Mark Souweidane, MD, Weill Cornell Brain and Spine Center
Manfred Westphal, MD, University Hospital Hamburg-Eppendorf

Registration, accommodations and additional program information will be posted as it becomes available.

We invite industry, pharmaceutical, and foundation support. To download the prospectus, click here.